Top-News
Pharmazeutika Großbritannien

Silence Therapeutics plc Aktie

Aktie
WKN:  A1T9PD ISIN:  GB00B9GTXM62 US-Symbol:  SLNCF
0,80 $
-0,17 $
-17,53%
0,7108 € 17.04.25
Depot/Watchlist
Aktienanzahl *
141,69 Mio.
Marktkapitalisierung *
123,11 Mio. €
Streubesitz
15,71%
KGV
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 09.05.2025

Silence Therapeutics plc News

17.04.20 - EQS
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN) 17-Apr-2020 / 09:33 GMT/BST London, UK, 1 7 ...
25.03.20 - EQS
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN) 25-March-2020 / 14:55 GMT/BST London, UK, 25 ...
09.01.20 - EQS
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
Edison Investment Research Limited Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN) 09-Jan-2020 / 10:03 GMT/BST London, UK, 9 J ...
18.07.19 - PR Newswire
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-​Mediated ...
18.07.19 - PR Newswire
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-​Mediated Diseases -- Collaboration advances ...
05.11.12 - PR Newswire
SILENCE THERAPEUTICS PLC - US allows two key patents for Silence Therapeutics
SILENCE THERAPEUTICS PLC - US allows two key patents for Silence Therapeutics PR Newswire
19.10.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Exercise of warrants
SILENCE THERAPEUTICS PLC - Exercise of warrants PR Newswire
16.10.12 - Aktiencheck
Silence Therapeutics-Aktie: Meilensteinzahlungen von bis zu 170 Mio. USD möglich - Hot Stocks Europe
Nach Meinung der Experten von "Hot Stocks Europe" sollen Anleger bei der Silence Therapeutics-​Aktie einen Fuß in die Tür stellen. Das Unternehmen bezeichne sich selbst als ...
15.10.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Exercise of warrants
SILENCE THERAPEUTICS PLC - Exercise of warrants PR Newswire
15.10.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Appointment of finance director
SILENCE THERAPEUTICS PLC - Appointment of finance director PR Newswire
25.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Interim Results for the Six Months Ended 30 June 2012
SILENCE THERAPEUTICS PLC - Interim Results for the Six Months Ended 30 June 2012 PR Newswire
20.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Notice of Results
SILENCE THERAPEUTICS PLC - Notice of Results PR Newswire
18.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Appointment of Chief Medical Adviser
SILENCE THERAPEUTICS PLC - Appointment of Chief Medical Adviser PR Newswire
10.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - TR-1: Notification of Major Interest in Shares
SILENCE THERAPEUTICS PLC - TR-1: Notification of Major Interest in Shares PR Newswire
10.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Significant Pre-clinical Data in Acute Lung Injury
SILENCE THERAPEUTICS PLC - Significant Pre-​clinical Data in Acute Lung Injury PR Newswire
04.09.12 - PR Newswire
SILENCE THERAPEUTICS PLC - TR-1: Notification of Major Interest in Shares
SILENCE THERAPEUTICS PLC - TR-1: Notification of Major Interest in Shares PR Newswire
24.08.12 - PR Newswire
SILENCE THERAPEUTICS PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
SILENCE THERAPEUTICS PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES PR Newswire
22.08.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Collaboration with MiReven Pty Ltd
SILENCE THERAPEUTICS PLC - Collaboration with MiReven Pty Ltd PR Newswire
20.08.12 - PR Newswire
SILENCE THERAPEUTICS PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
SILENCE THERAPEUTICS PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES PR Newswire
10.08.12 - PR Newswire
SILENCE THERAPEUTICS PLC - Holding(s) in Company
SILENCE THERAPEUTICS PLC - Holding(s) in Company PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr -0,04%
Technical Trading: DAX Long dienstags
DAX Long Typ: Turbo Open End WKN: NB17QL Hebel: 9 Laufzeit: OpenEnd Einstieg: Market ... Mehr »